Infomedtemas de salud
  • Universidad Virtual de Salud
  • Biblioteca Virtual de Salud
Sitio de la red de salud de Cuba sobre Medicina Regenerativa
Medicina Regenerativa
Home Acerca de Recursos de información
 
Inicio > Possible Predictors of Poor Angiogenesis after Hematopoietic Stem Cell Autograft for Lower Limb Ischemia.MEDICC Review July 2012,Rafael A. Gómez
02/08/2012

Possible Predictors of Poor Angiogenesis after Hematopoietic Stem Cell Autograft for Lower Limb Ischemia.MEDICC Review July 2012,Rafael A. Gómez

ago 2nd, 2012. #

Possible Predictors of Poor Angiogenesis after Hematopoietic Stem Cell Autograft for Lower Limb Ischemia.

href=”http://www.medicc.org/mediccreview/articles/mr_263.pdf”>Rafael A. Gómez MD, Julio D. Fernández MD, Maritza Cabrera MD, Ivón Marrero MD, Nancy Ramírez MD, Ivet Álvarez MD

INTRODUCTION The therapeutic potential of adult stem cells in coronary and peripheral arterial diseases has been proposed in recent years. However, factors possibly predictive of unfavorable angiogenic results have not been clearly identified as yet.

OBJECTIVES Identify candidate predictors of poor angiogenesis, as indicated by need for amputation, after autologous hematopoietic stem cell transplantation for chronic lower limb ischemia.

METHODS A retrospective analytical case-series study was carried out to detect factors possibly associated with hematopoietic stem cell autograft failure due to low angiogenic potential. The study universe was composed of 47 patients (19 women, 28 men) with critical lower limb ischemia in Fontaine stages IIb, III and IV, who received autologous stem cell transplantation at the Dr Gustavo Aldereguía Lima University General Hospital in Cienfuegos, Cuba, from January 2007 through December 2010. Variables studied were sex, age, medical history (high blood pressure, ischemic cardiomyopathy, diabetes mellitus and chronic renal insufficiency), Fontaine ischemia stage, intermittent claudication, pain score on a 1–10 scale, ankle-brachial pressure index in the affected extremity, presence of ulcers, and smoking. Laboratory variables included: blood concentrations of hemoglobin, glucose, creatinine, liver enzymes, cholesterol, triglycerides and LDH; as well as leukocyte and platelet counts, stem cell viability, prothrombin time and erythrocyte sedimentation rate. The main response variable was amputation, an indicator of poor angiogenesis. Using logistic regression, a prognostic score of 1 to 4 was developed for each risk factor and scores added to create a risk prediction scale. Predicted risk for amputation and observed amputation rates were compared for patients in three risk groups: low, 0–4; medium, 5–8; and high, 9–12.

RESULTS Factors identified as possibly predictive of poor angiogenesis were: final leukocyte count 6 mmol/L; and triglycerides of >1.8 mmol/L. Patients who scored low on predicted amputation risk scale were spared amputation in 90.9% (10/11) of cases, versus 16.7% (2/12) in patients scoring high.

CONCLUSIONS Five possible prognostic factors for low angiogenic potential in stem cell autotransplantation were identified and a preliminary scale established to predict in which patients autotransplantation would be more likely to be successful.

Enlaces de interés

  • Hematología
  • Inistituto de Hematología e Inmunología
  • Sociedad Internacional para investigacion en células madre
  • Ver más

Categorías

Archivos

Noticias

  • Nuevas perspectivas para el uso de las células madre.

    10-03-2016
  • El "impresionante" procedimiento con células madre que acaba con las cataratas

    10-03-2016
  • Explican los fallos de contractilidad tras las terapias celulares cardiacas

    13-02-2016
  • Crean estructuras renales mediante la conversión de células madre

    30-10-2015
  • Medicina regenerativa beneficia pacientes en Santiago de Cuba

    30-06-2015
  • Hospital cienfueguero inaugura departamento de Medicina Regenerativa con células madre

    17-06-2015
  • Crean la primera extremidad cultivada en laboratorio

    07-06-2015
  • Revierten el proceso de envejecimiento de las células madre en los músculos y en el cerebro

    19-05-2015
  • La quimera de la medicina regenerativa: ahora incuba órganos para personas en cerdos

    19-05-2015
  • Desvelan las dificultades de producir células del intestino, hígado y páncreas a partir de células madre

    07-04-2015

Actualización

Lanzamiento del Sitio 21 Junio 2007

Meta

  • Acceder
  • RSS de las entradas
  • RSS de los comentarios
  • WordPress.org
Dra. Elvira Dorticós Balea: Editor principal | Especialista de II Grado en Hematología, J' Dpto. Trasplante de Células Progenitoras Hematopoyéticas : Instituto de Hematología e Inmunología, MINSAP | Calzada de Aldabo y Calle E. Altahabana, Boyeros, La Habana,  10 300, Cuba  | Teléfs:  (537) 7643 1648 y (537) 7643 8042, Horario de atención: de lunes a viernes, 8:30 a.m. a 5:00 p.m.
Políticas del Portal. Los contenidos que se encuentran en Infomed están dirigidos fundamentalmente a profesionales de la salud. La información que suministramos no debe ser utilizada, bajo ninguna circunstancia, como base para realizar diagnósticos médicos, procedimientos clínicos, quirúrgicos o análisis de laboratorio, ni para la prescripción de tratamientos o medicamentos, sin previa orientación médica.
© 1999-2021 Infomed - Centro Nacional de Información de Ciencias Médicas
Made with the Semiologic theme • Boxed, Verde-Olivo skin by Denis de Bernardy